Atlas Venture Associates Opportunity II, LP's Net Worth
$10.1 Million
Who is Atlas Venture Associates Opportunity II, LP?
Atlas Venture Associates Opportunity II, LP has an estimated net worth of $10.1 Million. This is based on reported shares across multiple companies, which include Disc Medicine, Inc., Dyne Therapeutics, Inc., and Korro Bio, Inc..
SEC CIK
Atlas Venture Associates Opportunity II, LP's CIK is 0001935814
Past Insider Trading and Trends
2022 was Atlas Venture Associates Opportunity II, LP's most active year for acquiring shares with 1 total transactions. Atlas Venture Associates Opportunity II, LP's most active month to acquire stocks was the month of November. 2022 saw Atlas Venture Associates Opportunity II, LP paying a total of $10,000,016.70 for 934,581 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Disc Medicine, Inc. (IRON) Snapshot price: $65.62
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.11% | -150.00K |
$67.65 | -$10,147,500.00 | 2.3M |
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Homology Medicines, Inc. (FIXX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dyne Therapeutics, Inc. (DYN) Snapshot price: $21.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.98% | -46.53K |
$30.05 | -$1,398,346.70 | 2.31M |
Scheduled
|
Mar 1
| ||
Form 4
| -5.89% | -807.84K |
$24.32 | -$19,626,902.97 | 12.9M |
Scheduled
|
Feb 26 - Feb 28
| ||
Form 4
| -5.35% | -500.79K |
$22.68 | -$11,339,780.44 | 8.86M |
Scheduled
|
Feb 21 - Feb 23
| ||
Form 4
|
∞
| 934.58K |
$10.70 | $10,000,016.70 | 934.58K |
Dec 12
| |||
| No matching records found | |||||||||
Korro Bio, Inc. (KRRO) Snapshot price: $59.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.08% | 17.86K |
$56.00 | $999,992.00 | 195.07K |
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||